HikariQ, Inc announced that it has received an equity round of funding from Solasia Pharma K.K. on April 11, 2022. The investor will acquire 25% stake in the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27 JPY | 0.00% | +3.85% | -40.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.00% | 32.15M | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- 4597 Stock
- News Solasia Pharma K.K.
- HikariQ, Inc announced that it has received funding from Solasia Pharma K.K.